Submitted by Anonymous (not verified) on 18 December 2024 - 15:57
Human medicines European public assessment report (EPAR): Simulect, basiliximab, Date of authorisation: 09/10/1998, Revision: 29, Status: Authorised
Source:
Human medicines European public assessment report (EPAR): Simulect, basiliximab, Date of authorisation: 09/10/1998, Revision: 29, Status: Authorised